MedDataX Logo

Nutritional Problems in Pallative Cancer

NCT ID: NCT04846985

Last Updated: 2021-10-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

44 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-04-26

Study Completion Date

2021-10-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to investigate those nutritional problems contributing to loss of lean body mass in lung and pancreas cancer patients in chemotherapy. Furthermore to investigate alterations in taste and how they correlates with changes in following factors: nutritional intake, physical activity, appetite, food preferences, side effects, fatique and meal perception.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will include a recruitment of 50 lung and pancreas cancer patients currently in chemotherapy. They will be observed during a period of 9-12 week, including at least 2 chemotherapy treatments. The presence and severity of the nutritional problems will be examined by observing as many different factors as possible. This includes taste alterations, weight changes, nutritional intake, physical activity, interviews and weekly questionnaires. In relation to this our primary outcome is to investigate the correlation between changes in taste and changes in nutritional intake. Secondarily the investigators want to investigate nutritional intake, physical activity, appetite, food preferences, side effects, fatique and meal perception.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Cancer Pancreatic Cancer

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Malnutrition cancer weight loss lean body mass

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Lung or pancreas cancer patient
* In chemoterapy regardless of line treatment with/without combined treatment
* Legal age
* Able to speak and read in danish
* Ambulant

Exclusion Criteria

* Inability to give consent and complete questionnaires
* Participating in clinical interventions during the periode of observation
* Allergic to milk or for any reason don't consume diary products
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hillerod Hospital, Denmark

OTHER

Sponsor Role collaborator

Jens Rikardt Andersen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jens Rikardt Andersen

Associate Professor, Primary Investigator

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Maria Elisabeth Lendorf, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Hillerod Hospital, Denmark

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hillerod hospital, Denmark

Hillerød, Region Sjælland, Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H-20083532

Identifier Type: -

Identifier Source: org_study_id